Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · IEX Real-Time Price · USD
177.61
-4.66 (-2.56%)
At close: Jul 2, 2024, 4:00 PM
176.50
-1.11 (-0.62%)
After-hours: Jul 2, 2024, 7:06 PM EDT

Krystal Biotech Revenue

Krystal Biotech had revenue of $95.95M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $45.25M. In the year 2023, Krystal Biotech had annual revenue of $50.70M.

Revenue (ttm)
$95.95M
Revenue Growth
n/a
P/S Ratio
52.86
Revenue / Employee
$418,991
Employees
229
Market Cap
5.07B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202350.70M--
Dec 31, 20220--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Grifols 7.32B
Organon & Co. 6.35B
Bausch + Lomb 4.31B
DENTSPLY SIRONA 3.94B
R1 RCM 2.31B
Lantheus Holdings 1.37B
Stevanato Group 1.18B
Tempus AI 562.02M
Revenue Rankings